BACKGROUND: Breast cancer appears to be more aggressive in young women (< or =35 years). Race/ethnicity may further influence prognosis. The purpose of this review is to determine whether breast cancer in young Latinas differs from that in other women. METHODS: Our institutional (1977-2000) and state (1988-2000) tumor registries were reviewed and breast cancer cases analyzed. Data are expressed as mean +/- SEM. RESULTS: At our institution, 56 (7%) of 748 breast cancer patients were < or =35 years old; 32 (57%) were Latina. Compared with non-Latinas, Latinas presented at a younger age (P <0.05) and had more stage III/IV disease (38% versus 29%; P >0.05) and bilaterality (22% versus 8%; P >0.05), and worse 5-year survival (63% versus 83%; P >0.05). Statewide data were consistent with our institutional data. CONCLUSIONS: Latinas comprise a disproportionate share of our young breast cancer population, and may suffer more aggressive disease than other young women. Young Latinas may benefit from more vigilant screening and should be considered for novel therapeutic protocols.
BACKGROUND:Breast cancer appears to be more aggressive in young women (< or =35 years). Race/ethnicity may further influence prognosis. The purpose of this review is to determine whether breast cancer in young Latinas differs from that in other women. METHODS: Our institutional (1977-2000) and state (1988-2000) tumor registries were reviewed and breast cancer cases analyzed. Data are expressed as mean +/- SEM. RESULTS: At our institution, 56 (7%) of 748 breast cancerpatients were < or =35 years old; 32 (57%) were Latina. Compared with non-Latinas, Latinas presented at a younger age (P <0.05) and had more stage III/IV disease (38% versus 29%; P >0.05) and bilaterality (22% versus 8%; P >0.05), and worse 5-year survival (63% versus 83%; P >0.05). Statewide data were consistent with our institutional data. CONCLUSIONS: Latinas comprise a disproportionate share of our young breast cancer population, and may suffer more aggressive disease than other young women. Young Latinas may benefit from more vigilant screening and should be considered for novel therapeutic protocols.
Authors: Patricia Y Miranda; Anna V Wilkinson; Carol J Etzel; Renke Zhou; Lovell A Jones; Patricia Thompson; Melissa L Bondy Journal: Cancer Date: 2011-01-15 Impact factor: 6.860
Authors: Mehdi Owrang; Robert L Copeland; Luisel J Ricks-Santi; Melvin Gaskins; Desta Beyene; Robert L Dewitty; Yasmine M Kanaan Journal: In Vivo Date: 2017 Jul-Aug Impact factor: 2.155
Authors: Olivia S Fu; Katherine D Crew; Judith S Jacobson; Heather Greenlee; Gary Yu; Julie Campbell; Yvette Ortiz; Dawn L Hershman Journal: J Cancer Surviv Date: 2009-10-27 Impact factor: 4.442
Authors: Jennifer J Griggs; Sarah T Hawley; John J Graff; Ann S Hamilton; Reshma Jagsi; Nancy K Janz; Mahasin S Mujahid; Christopher R Friese; Barbara Salem; Paul H Abrahamse; Steven J Katz Journal: J Clin Oncol Date: 2012-08-06 Impact factor: 44.544
Authors: J K Chan; R Urban; M K Cheung; K Osann; J Y Shin; A Husain; N N Teng; D S Kapp; J S Berek; G S Leiserowitz Journal: Br J Cancer Date: 2006-10-31 Impact factor: 7.640